Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy
Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy
复制标题
DOI：
10.1177/0003122412458509
复制
发表时间：
2012-10-01
影响因子：
9.1
通讯作者：
Best, Rachel Kahn
中科院分区：
文献类型：
--
作者：
Best, Rachel Kahn
在20世纪80年代和90年代，单一疾病利益集团在美国成为一股有影响力的力量。S.政治本文探讨了它们对联邦医学研究优先权设置的影响。以前对倡导组织的政治影响的研究狭隘地集中在对选民的直接利益上。使用19年来53种疾病的数据，我发现，除了确保直接利益外，倡导组织还具有综合效应，可以系统地改变政策领域的文化。疾病宣传重塑了资金分配，改变了政策受益者的感知，促进了康复指标，并使文化价值类别与决策越来越相关。
In the 1980s and 1990s, single-disease interest groups emerged as an influential force in U. S. politics. This article explores their effects on federal medical research priority-setting. Previous studies of advocacy organizations' political effects focused narrowly on direct benefits for constituents. Using data on 53 diseases over 19 years, I find that in addition to securing direct benefits, advocacy organizations have aggregate effects and can systemically change the culture of policy arenas. Disease advocacy reshaped funding distributions, changed the perceived beneficiaries of policies, promoted metrics for commensuration, and made cultural categories of worth increasingly relevant to policymaking.